Subscribe
eNewsletter
Ready to get certified?
Free CDCES Coach App
Download
Free Med Pocket Cards
eNewsletter
Free CDCES Coach App
Free Med Pocket Cards
A person with diabetes comes to your clinic and states she lost her spouse 18 months ago. She continues to have prolonged grief, shame, and guilt. She expresses how this … Continue reading Question of the Week | Self-Efficacy and DSMES
For last week’s practice question, we quizzed participants on the best medication for HFpEF. 79% of respondents chose the best answer. We want to clarify and share this important information, … Continue reading Rationale of the Week | Best Med for HFpEF
Author: Beverly Thomassian, RN, MPH, CDCES, BC-ADM CEO & President, DiabetesEd Services For decades, healthcare professionals have cared for individuals diagnosed with Polycystic Ovary Syndrome (PCOS), a condition that affects … Continue reading From PCOS to PMOS: Why the Renaming of PCOS Matters
A 42-year-old woman with type 2 diabetes presents for follow-up. She reports trying to lose weight by “cutting carbs,” but admits she often skips meals during the day and overeats … Continue reading Question of the Week | Meal Skipping and Postprandial Hyperglycemia
Celebrations are in order! June is Pride Month – a time to honor diversity, inclusion, and the freedom to be authentically ourselves. It’s also a special month for another reason … Continue reading June 2026 e-News | PCOS Renamed & PocketCard Updates
For last week’s practice question, we quizzed participants on A1C 7.4% & struggling with hypoglycemia. 83% of respondents chose the best answer. We want to clarify and share this important … Continue reading Rationale of the Week | A1C 7.4% & Struggling with Hypoglycemia
JL has T2DM, and heart failure with preserved ejection fraction (HFpEF). Is currently on Metformin 1000mg BID and empagliflozin 25mg daily. Their A1C is 8.1%. Which agent should be added … Continue reading Question of the Week | What’s the best medication for HFpEF?
For last week’s practice question, we quizzed participants on who would most benefit from metformin therapy. 63.26% of respondents chose the best answer. We want to clarify and share this … Continue reading Rationale of the Week | Who would most benefit from metformin therapy?